EPHB4
Ephrin type-B receptor 4
Also known as: EPHB4_HUMAN, HTK, Tyro11
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P54760
- Gene
- EPHB4
- Ensembl
- ENSG00000196411
- Chromosome
- 7
- Canonical length
- 987 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene binds to ephrin-B2 and plays an essential role in vascular development. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
987 residues, UniProt reviewed canonical sequence.
>P54760|EPHB4
1 MELRVLLCWA SLAAALEETL LNTKLETADL KWVTFPQVDG QWEELSGLDE EQHSVRTYEV
61 CDVQRAPGQA HWLRTGWVPR RGAVHVYATL RFTMLECLSL PRAGRSCKET FTVFYYESDA
121 DTATALTPAW MENPYIKVDT VAAEHLTRKR PGAEATGKVN VKTLRLGPLS KAGFYLAFQD
181 QGACMALLSL HLFYKKCAQL TVNLTRFPET VPRELVVPVA GSCVVDAVPA PGPSPSLYCR
241 EDGQWAEQPV TGCSCAPGFE AAEGNTKCRA CAQGTFKPLS GEGSCQPCPA NSHSNTIGSA
301 VCQCRVGYFR ARTDPRGAPC TTPPSAPRSV VSRLNGSSLH LEWSAPLESG GREDLTYALR
361 CRECRPGGSC APCGGDLTFD PGPRDLVEPW VVVRGLRPDF TYTFEVTALN GVSSLATGPV
421 PFEPVNVTTD REVPPAVSDI RVTRSSPSSL SLAWAVPRAP SGAVLDYEVK YHEKGAEGPS
481 SVRFLKTSEN RAELRGLKRG ASYLVQVRAR SEAGYGPFGQ EHHSQTQLDE SEGWREQLAL
541 IAGTAVVGVV LVLVVIVVAV LCLRKQSNGR EAEYSDKHGQ YLIGHGTKVY IDPFTYEDPN
601 EAVREFAKEI DVSYVKIEEV IGAGEFGEVC RGRLKAPGKK ESCVAIKTLK GGYTERQRRE
661 FLSEASIMGQ FEHPNIIRLE GVVTNSMPVM ILTEFMENGA LDSFLRLNDG QFTVIQLVGM
721 LRGIASGMRY LAEMSYVHRD LAARNILVNS NLVCKVSDFG LSRFLEENSS DPTYTSSLGG
781 KIPIRWTAPE AIAFRKFTSA SDAWSYGIVM WEVMSFGERP YWDMSNQDVI NAIEQDYRLP
841 PPPDCPTSLH QLMLDCWQKD RNARPRFPQV VSALDKMIRN PASLKIVARE NGGASHPLLD
901 QRQPHYSAFG SVGEWLRAIK MGRYEESFAA AGFGSFELVS QISAEDLLRI GVTLAGHQKK
961 ILASVQHMKS QAKPGTPGGT GGPAPQYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPHB4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 56 nTPM
- cervix: 51 nTPM
- adrenal gland: 47 nTPM
- spleen: 46 nTPM
- ovary: 35 nTPM
- skin: 34 nTPM
Single-cell type
- syncytiotrophoblasts: 292 nCPM
- cytotrophoblasts: 106 nCPM
- lymphatic endothelial cells: 96 nCPM
- vascular endothelial cells: 74 nCPM
- gastric progenitor cells: 49 nCPM
- migrating cytotrophoblasts: 45 nCPM
Immune cell
- neutrophil: 4.3 nTPM
- classical monocyte: 2 nTPM
- myeloid DC: 0.9 nTPM
- total PBMC: 0.7 nTPM
- intermediate monocyte: 0.5 nTPM
- non-classical monocyte: 0.1 nTPM
Brain region
- choroid plexus: 10 nTPM
- thalamus: 9 nTPM
- pons: 6.9 nTPM
- medulla oblongata: 6.8 nTPM
- spinal cord: 6.6 nTPM
- midbrain: 6.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EPHB4.
Disease | AllUniProt
Conditions EPHB4 is implicated in, by any mechanism.
- Lymphatic malformation 7 (LMPHM7) MIM:617300
- Capillary malformation-arteriovenous malformation 2 (CMAVM2) MIM:618196
Disease | GeneticClinVar
136 pathogenic / likely-pathogenic of 1,114 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Capillary malformation-arteriovenous malformation 2
- Lymphatic malformation 7
- EPHB4-related disorder
- Cardiovascular phenotype
- Capillary malformation-arteriovenous malformation syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 2.3
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cell adhesion
- cell migration involved in sprouting angiogenesis
- ephrin receptor signaling pathway
- heart morphogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Ephrin, ligand binding domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Tyrosine-protein kinase, receptor class V, conserved site
- Sterile alpha motif domain
- Fibronectin type III
- Tyrosine-protein kinase, active site
- Galactose-binding-like domain superfamily
- Growth factor receptor cysteine-rich domain superfamily
- Protein kinase-like domain superfamily
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Sterile alpha motif/pointed domain superfamily
- Immunoglobulin-like fold
- Ephrin receptor type-A /type-B
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- Ephrin, transmembrane domain
- Fibronectin type III superfamily
- Ephrin receptor tyrosine kinases
- Fibronectin type III domain
- SAM domain (Sterile alpha motif)
- Ephrin receptor ligand binding domain
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Protein tyrosine and serine/threonine kinase
- Ephrin type-A receptor 2 transmembrane domain
- Ephrin cysteine rich domain
- Ephrin type-B receptor 4, ligand binding domain
- EPH-B4, SAM domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EPHB4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPHB4 as an antibody target. Whether an autoantibody or antibody against EPHB4 could matter depends on whether native EPHB4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPHB4 is annotated at the cell surface, where native EPHB4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EPHB4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...